Search
for
Sort by
Research 211–240 of 796
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Acne in women
- Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Alopecia and Hirsuties
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Disorders of ovulation
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Acupuncture improves anxiety and depression in patients with polycystic ovary syndrome: a systematic evaluation and meta-analysis
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Association of Cyp11a Gene with Polycystic Ovarian Syndrome Patients in Lahore, Pakistan
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- THE GENETICS OF CYP GENE VARIANTS IN ASSOCIATION WITH POLYCYSTIC OVARY SYNDROME: A NARRATIVE REVIEW
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Unravelling the link between insulin resistance and androgen excess
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Mucocutaneous reactions to chemotherapy
- Polycystic Ovary Syndrome
- Female pattern hair loss